BioAdaptives, Inc.
BDPT
$0.0653
-$0.0147-18.38%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -100.00% | -- | -69.57% | 252.94% | 80.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -100.00% | -- | -69.57% | 252.94% | 80.00% |
| Cost of Revenue | -100.00% | 445.45% | 2,600.00% | 500.00% | 50.00% |
| Gross Profit | -100.00% | -1,376.60% | -1,493.33% | 80.00% | 170.00% |
| SG&A Expenses | 347.94% | 4.56% | -4.75% | 153.69% | 172.83% |
| Depreciation & Amortization | 100.00% | -- | -- | 171.43% | -1,642.86% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 388.84% | 12.97% | 29.85% | 175.89% | 120.45% |
| Operating Income | -445.79% | -32.21% | -34.17% | -162.11% | -126.37% |
| Income Before Tax | -38.58% | -187.02% | -27.17% | -6.79% | -848.06% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -38.58% | -187.02% | -27.17% | -6.79% | -848.06% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.58% | -187.02% | -27.17% | -6.79% | -848.06% |
| EBIT | -445.79% | -32.21% | -34.17% | -162.11% | -126.37% |
| EBITDA | -516.64% | -123.26% | -35.62% | -161.75% | -105.64% |
| EPS Basic | -98.41% | -133.33% | 37.42% | 70.89% | 14.86% |
| Normalized Basic EPS | -27.87% | -120.42% | 43.28% | 70.90% | -31.65% |
| EPS Diluted | -98.41% | -133.33% | 37.42% | 70.89% | 14.86% |
| Normalized Diluted EPS | -27.87% | -120.42% | 43.28% | 70.90% | -31.65% |
| Average Basic Shares Outstanding | -30.36% | 22.71% | 102.78% | 266.54% | 1,016.42% |
| Average Diluted Shares Outstanding | -30.36% | 22.71% | 102.78% | 266.54% | 1,016.42% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |